This Article Full Text Full Text (PDF) All Versions of this Article: 2003-0268OCv1 30/3/311    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Swanson, K. A. Articles by Wilkes, D. S. Search for Related Content PubMed PubMed Citation Articles by Swanson, K. A. Articles by Wilkes, D. S.

CDllc⁺ Cells Modulate Pulmonary Immune Responses by Production of Indoleamine 2,3-Dioxygenase

Departments of Microbiology and Immunology and of Medicine, Indiana University School of Medicine, Indianapolis, Indiana; and Department of Thoracic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan

Address correspondence to: David S. Wilkes, M.D., Division of Pulmonary and Critical Care Medicine, Indiana University School of Medicine, 1001 West Tenth Street, OPW 425, Indianapolis, IN 46202. E-mail: dwilkes{at}iupui.edu

Interactions between antigen-presenting cells and T cells can result in T cell activation or suppression. With the use of RNA analysis, high-performance liquid chromatography, mixed leukocyte reactions (MLRs), and animal models, the current study reports that lung interstitial antigen-presenting cells (iAPCs, CDllc⁺) suppress T cell responses in vitro and in vivo by production of indoleamine 2,3-dioxygenase (IDO), an enzyme that catabolizes tryptophan to its byproduct, kynurenine. IDO mRNA expression was unique to lung iAPCs, as cells similarly isolated from the liver and spleen did not express IDO constitutively, or in response to interferon-. Lung iAPCs suppressed proliferation of allogeneic T cells, correlating with increased kynurenine levels; and blockade of IDO activity with 1-methyl-DL-tryptohan (1-MT) or addition of exogenous tryptophan recovered T cell proliferation in MLRs. In contrast, liver and splenic iAPCs were potent stimulators of T cells in MLRs, and IDO inhibition had no effect on T cell responses. In vivo studies showed that systemic blockade of IDO resulted in spontaneous proliferation in lung T cells and pulmonary inflammation. Finally, overexpressing IDO in lung transplants abrogated acute allograft rejection, a T cell–mediated disease. Collectively these data show that lung iAPCs contribute to local regulation of cellular immune responses by production of IDO.

Abbreviations: 1-methyl-DL-tryptophan, 1-MT • alveolar macrophage, AM • counts per minute, CPM • dendritic cell, DC • delayed-type hypersensitivity, DTH • high-performance liquid chromatography, HPLC • interstitial antigen presenting cell, iAPC • indoleamine 2,3-dioxygenase, IDO • interferon-, IFN- • lipopolysaccharide, LPS • mixed leukocyte reaction, MLR • macrophage, M

This article has been cited by other articles:

				L. R. Guerin, J. R. Prins, and S. A. Robertson Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment? Hum. Reprod. Update, September 1, 2009; 15(5): 517 - 535. [Abstract] [Full Text] [PDF]

				M. Nakahara, Y. Nagayama, O. Saitoh, R. Sogawa, S. Tone, and N. Abiru Expression of Immunoregulatory Molecules by Thyrocytes Protects Nonobese Diabetic-H2h4 Mice from Developing Autoimmune Thyroiditis Endocrinology, March 1, 2009; 150(3): 1545 - 1551. [Abstract] [Full Text] [PDF]

				R. B. Jalili, F. Forouzandeh, A. Moeenrezakhanlou, G. R. Rayat, R. V. Rajotte, H. Uludag, and A. Ghahary Mouse Pancreatic Islets Are Resistant to Indoleamine 2,3 Dioxygenase-Induced General Control Nonderepressible-2 Kinase Stress Pathway and Maintain Normal Viability and Function Am. J. Pathol., January 1, 2009; 174(1): 196 - 205. [Abstract] [Full Text] [PDF]

				C. A. Beamer and A. Holian Silica suppresses Toll-like receptor ligand-induced dendritic cell activation FASEB J, June 1, 2008; 22(6): 2053 - 2063. [Abstract] [Full Text] [PDF]

				H. Xu, T. B. Oriss, M. Fei, A. C. Henry, B. N. Melgert, L. Chen, A. L. Mellor, D. H. Munn, C. G. Irvin, P. Ray, et al. Indoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammation PNAS, May 6, 2008; 105(18): 6690 - 6695. [Abstract] [Full Text] [PDF]

				L. K. Jasperson, C. Bucher, A. Panoskaltsis-Mortari, P. A. Taylor, A. L. Mellor, D. H. Munn, and B. R. Blazar Indoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethality Blood, March 15, 2008; 111(6): 3257 - 3265. [Abstract] [Full Text] [PDF]

				D.-Y. Hou, A. J. Muller, M. D. Sharma, J. DuHadaway, T. Banerjee, M. Johnson, A. L. Mellor, G. C. Prendergast, and D. H. Munn Inhibition of Indoleamine 2,3-Dioxygenase in Dendritic Cells by Stereoisomers of 1-Methyl-Tryptophan Correlates with Antitumor Responses Cancer Res., January 15, 2007; 67(2): 792 - 801. [Abstract] [Full Text] [PDF]

				R. L. Seymour, V. Ganapathy, A. L. Mellor, and D. H. Munn A high-affinity, tryptophan-selective amino acid transport system in human macrophages J. Leukoc. Biol., December 1, 2006; 80(6): 1320 - 1327. [Abstract] [Full Text] [PDF]

				H. Liu, L. Liu, B. S. Fletcher, and G. A. Visner Sleeping Beauty-based gene therapy with indoleamine 2,3-dioxygenase inhibits lung allograft fibrosis FASEB J, November 1, 2006; 20(13): 2384 - 2386. [Abstract] [Full Text] [PDF]

				H. Liu, L. Liu, B. S. Fletcher, and G. A. Visner Novel Action of Indoleamine 2,3-Dioxygenase Attenuating Acute Lung Allograft Injury Am. J. Respir. Crit. Care Med., March 1, 2006; 173(5): 566 - 572. [Abstract] [Full Text] [PDF]

				A. T. Thiele, T. L. Sumpter, J. A. Walker, Q. Xu, C.-H. Chang, R. L. Bacallao, R. Kher, and D. S. Wilkes Pulmonary Immunity to Viral Infection: Adenovirus Infection of Lung Dendritic Cells Renders T Cells Nonresponsive to Interleukin-2 J. Virol., February 15, 2006; 80(4): 1826 - 1836. [Abstract] [Full Text] [PDF]

				K. Vermaelen and R. Pauwels Pulmonary Dendritic Cells Am. J. Respir. Crit. Care Med., September 1, 2005; 172(5): 530 - 551. [Abstract] [Full Text] [PDF]